Future: These good clinical practices are leading to error reduction and increased data validity. Our objective for the 2016 audit is to demonstrate below 1% total errors and attain reciprocal data between electronic medical records, internal databases, and CIBMTR by implementing one innovative process per quarter.
Background: Historically, Hematopoietic Stem Cell (HSC) Infusion was documented on a standard paper form available from a document library throughout the institution. Once complete, the form remained in the patient's chart until discharge at which time the chart was scanned into the EMR. This limited the availability and portability of the information. Completion of this form was the responsibility of the clinician infusing the HSC product. Additionally, HSC infusions are conducted in a variety of units throughout MSKCC. These areas have been divided into 5 major groups.
The Bone Marrow Transplant Quality Assessment Committee (BMT QAC) conducted a compliance audit of infusion documentation. The timeframe used for the audit was October 2010 through March 2011, which included a total of 194 transplants. A random selection of 50 transplants (10 from each major group) during this 6 month period was reviewed; resulting in a total of 60 forms (10 of which were double cord transplants requiring 2 forms). Seven key elements of the form were identified based on regulatory and institutional requirements and audited for completeness. The results of the audit indicated that documentation compliance was 77%. Intervention: To improve documentation compliance of HSC Infusions, we developed an electronic infusion form. The building and testing of the form lasted approximately one year. Simultaneously, we modified our vital sign monitoring parameters for better standardization between different cell types. During this time period, infusion Standard Operating Procedure (SOP) was revised to incorporate use of the electronic document and standardized vital sign parameters. The design of the electronic form required all fields to be complete prior to final electronic signature and acceptance of the form. Additionally, Infusion vitals entered into the electronic flowsheet by the RN were imported into the note by the documenting clinician. Subsequent to distribution of the SOP and training of Stem Cell Transplant service (Physicians, Nurse Practitioners, Registered Nurses and Cell Processing Technicians) the form went live in March 2012. Three weeks post roll out to all areas, the paper form was removed from the document library; however the form will be available during system downtime. Outcome: A follow up audit was conducted to measure compliance post implementation of electronic documentation. The timeframe for the audit was April 2012 through July 2012, a total of 209 transplants. Similar to the pre-implementation audit, a random selection of 50 transplants from the 5 major groups during this 4 month period were reviewed for a total of 60 forms. The same 7 key elements of the form were audited for completeness. The results of the post implementation audit indicated that compliance of documentation improved from 77% to 92%, an improvement of 15%. The System Capacity Initiative (SCI), sponsored by the National Marrow Donor Program (NMDP), was convened to evaluate and provide recommendations for addressing workforce and infrastructure challenges for current and future utilization of blood and marrow transplant (BMT). The Nursing Workforce Group (NWG) was established to address projected shortages of BMT nurses. After surveying BMT nurses, the NWG identified several priority challenges, including the recruitment of nurses to the BMT field. In an effort to increase the number of BMT nurses, an outreach presentation entitled 'Introduction to BMT' was developed and delivered to nursing students throughout the U.S. The one-hour presentation describes the BMT process, identifies various nursing roles in BMT, and describes the benefits of working in this area. A brief pre and post survey is administered to assess the students' change in awareness of BMT as a career option, nursing career preferences, likelihood of pursuing a BMT career, and previous education/training in BMT after listening to the presentation. To date, the presentation, and pre and post surveys, was delivered to a total of 181 nursing students. The majority of students had not previously considered a career in BMT (56.9%). However, the presentation significantly increased nursing students' interest in pursuing a BMT career (N¼61; P < .0001). Additionally, students' indicated that 'feeling valued' (62.5%), 'intellectual stimulation' (66.3%), 'emotional gratification of providing patient care' (69.5%) and 'interest in subject matter' (69.5%) were very important career aspects (see Figure 1 ). The NWG in partnership with Oncology Nursing Society (ONS) and American Society for Blood and Marrow Transplantation (ASBMT) is continuing to promote the presentation to increase awareness of BMT nursing as a career option. It will be available for professional Abstracts / Biol Blood Marrow Transplant 19 (2013) S167eS177 S171 development of licensed nurses and continuing nursing education credit will be provided. The adult blood and marrow transplant population is at high risk for central line associated bloodstream infections (CLABSI). CLABSI remains a large cause of morbidity, increased cost, prolonged hospitalization and mortality in this population. One source of these infections is line manipulation; specifically at the central venous access device (CVAD) needless hub. Several studies have consistently found yeast and heavy bacterial contamination on the surface of the CVAD hub. Our aim was to decrease line manipulation in order to decrease our unit's CLABSI rate. Implementation: In late 2010 our unit practice council created new guidelines for accessing and maintaining central lines. These guidelines included: patients on continuous IVs will not be disconnected to shower, walk, etc. and patients whose lines are accessed greater than two time a day (excluding labs) will remain connected continuously at a provider prescribed rate. Our definition of each access included one connection and disconnection. This prompted a process improvement initiative. Goals were to improve quality outcomes by increasing reliability of TAC/ CSA levels and resulting dose adjustments and improve patient satisfaction with the process (lumen contamination necessitates peripheral sampling causing increased discomfort and risk for patients).
The BMT Leadership team reviewed potential causes: Forty new staff hired; census and acuity were higher; Travelers and float staff were utilized. A process was needed to ensure TAC/CSA levels were reliable and bedside caregivers had appropriate knowledge to manage TAC/CSA infusions and samplings.
Intervention: Immediate efforts focused on nursing staff re-education.
